Foreign pharmaceuticals, active pharmaceutical ingredients (APIs), and other regulated drug products are more accessible than ever before. The internet fosters direct transactions between consumers and foreign retailers. Many physicians and practitioners purchase products from foreign sources in their routine practice. But certain drug products may not be “approved” for sale in the United States market. […]
WASHINGTON, D.C.—On August 2, 2012, Rep. Ron Paul (R-TX14) introduced the “Compassionate Freedom of Choice Act,” H.R. 6342, a Bill designed to “allow the importation, distribution, and sale of investigational drugs and devices intended for use by terminally ill patients who execute an informed consent document.” Rep. Paul Broun (R-GA10) and Rep. Richard Hanna (R-NY24) […]
Whether evaluating a concept, performing regulatory due diligence, maintaining or prosecuting regulatory filings, or contesting adverse litigation, Emord & Associates provides exceptional counsel for all your litigation and regulatory needs.
11808 Wolf Run Lane
Clifton, VA 20124
Telephone: (202) 466-6937
Telecopier: (202) 466-6938
